Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China

BACKGROUND: Alpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular carcinoma (HCC). However, only limited AFP-related studies have evaluated its early response to systemic therapy. This study was performed with the aim of assessing the value of early AFP response in predicting over...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Gang, Liu, Bo, Fan, Zhong-Qi, Li, Chao, Zhang, Jian-Ping, Guo, Yan-Hui, Zhang, Ru-Yi, Zheng, Yi, Zhu, Hong, Wang, Nan-Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846773/
https://www.ncbi.nlm.nih.gov/pubmed/36686731
http://dx.doi.org/10.3389/fonc.2022.1094104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846773/
https://www.ncbi.nlm.nih.gov/pubmed/36686731
http://dx.doi.org/10.3389/fonc.2022.1094104

Ejemplares similares